Communication Enhancement Among Ventilated Patients in Intensive Care
CESAR
1 other identifier
observational
60
1 country
3
Brief Summary
Intensive care is a unit that admits ventilated patients. Hospitalization is extremely challenging for these patients. Their vital prognosis is at stake, and they often have difficulty moving due to pain, edema, neuromyopathy, or the presence of monitoring cables. They are also hindered in their communication: they cannot speak because of the presence of the intubation tube between their vocal cords or the tracheostomy cannula with the inflated cuff. Every day, in each intensive care unit, about 50% of ventilated patients are conscious and face communication difficulties. They describe this difficulty as a "nightmare." This leads to challenges in care management and increases the anxiety caused by hospitalization in the intensive care unit. A large proportion of patients will develop post-intensive care syndrome. The tools currently used are not efficient. Moreover, many patients have comprehension difficulties due to the medications administered to them (sedatives) or due to the initial or secondary pathologies related to their hospitalization (confusional syndrome, ICU delirium). Our objective is to implement an adapted and personalized communication tool for ventilated patients in intensive care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedStudy Start
First participant enrolled
March 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
May 4, 2026
April 1, 2026
1.2 years
July 24, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of successful uses of the "JIB-Tours care" device
A "successful" use is defined as (cumulative criteria, in chronological order): * Activation of the device by the caregiver * Completion of the mobility questionnaire * Setup of the device in front of the eligible patient * Successful calibration of the eye-tracking control * Completion of the comprehension assessment test * Transition to the adapted communication interface * Use of the communication interface by the patient by clicking on the icon requested by the caregiver
Day 1
Secondary Outcomes (5)
Duration of device setup in front of the patient
Day 1
Recording of failures according to their occurrence time
Day 1
Communication success rate
Day 1
Collection of device improvement suggestions through a feedback questionnaire from users (caregivers, patients, and relatives)
Day 28
User satisfaction (patients, relatives, and caregivers) with the use of the "JIB-Tours care" device
Day 28
Interventions
The innovative device "JIB-Tours care" is equipped with a tablet featuring eye-tracking control and software specifically dedicated to communication in an intensive care unit. The eye-tracking control allows the tablet to be used with the gaze, similar to how a computer mouse is usually used.
Eligibility Criteria
Participants admitted to the Intensive Care Unit of the University Hospital of Tours or Orleans or Le Mans (France)
You may qualify if:
- Intubated ventilated ICU patient
- Hospitalized patient with an inflated cuff tracheostomy
- conscious patient, able to open and close eyes on demand
- of-age patient
- French speaking
You may not qualify if:
- Patient with uncorrected visual impairment or hearing deficiency
- opposed to the processing of personal data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Intensive care, Hospital, Le MANS
Le Mans, France
Intensive care, University Hospital, Orléans
Orléans, France
Intensive care, University Hospital
Tours, 37000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laetitia BODET-CONTENTIN, MD PhD
Intensive care, University Hospital, Tours
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2025
First Posted
November 26, 2025
Study Start
March 19, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04